Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
14.07.25
/
50%
€24.00
Target price
14.07.26
€47.06
Performance (%)
-13.33%
Price
16.04.26
?
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.33%. This prediction currently runs until 14.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3.922% | 3.922% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Morgan Stanley from $65.00 to $55.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.80
16.04.26
16.04.26
€56.70
16.04.27
16.04.27
0.00%
16.04.26
16.04.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€31.20
09.05.25
09.05.25
€57.96
09.05.26
09.05.26
-33.33%
16.04.26
16.04.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
30.05%
04.11.24
04.11.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
10.10.23
10.10.23
€84.74
10.10.24
10.10.24
43.02%
11.10.24
11.10.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.60
04.08.23
04.08.23
€86.28
04.08.24
04.08.24
30.06%
05.08.24
05.08.24